Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Gordon Cook
Woman and Man Max 99 years
Gordon Cook
Update Il y a 4 ans
Viral Immunotherapy in Relapsed/Refractory Multiple Myeloma
This study will recruit patients currently receiving either lenalidomide or pomalidomide whose disease is relapsing. This is a dose escalation study and the aim is to determine the maximum...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Gordon Cook
Update Il y a 4 ans
Phase II Randomised Trial of Cyclophosphamide and Dexamethasone in Combination With Ixazomib in Relapsed or Refractory Multiple Myeloma
This study evaluates a new treatment combination of ixazomib with cyclophosphamide and dexamethasone in relapsed or refractory multiple myeloma. Participants will either receive ixazomib w...
Country
None
organs
None
Specialty
None
Opened trial
More information
Woman and Man Max 99 years
Gordon Cook, MD, PhD
Update Il y a 4 ans
High-Dose Melphalan and a Second Stem Cell Transplant or Low-Dose Cyclophosphamide in Treating Patients With Relapsed Multiple Myeloma After Chemotherapy
RATIONALE: Giving chemotherapy and bortezomib before a peripheral stem cell transplant stops the growth of cancer cells by stopping them from dividing or killing them. Giving colony-stimul...
Country
None
organs
None
Specialty
None
unknown
More information